These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33222122)

  • 1. Effects of growth hormone on cognitive, motor, and behavioral development in Prader-Willi syndrome children: a meta-analysis of randomized controlled trials.
    Luo Y; Zheng Z; Yang Y; Bai X; Yang H; Zhu H; Pan H; Chen S
    Endocrine; 2021 Feb; 71(2):321-330. PubMed ID: 33222122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive function during 3 years of growth hormone in previously growth hormone-treated young adults with Prader-Willi syndrome.
    Trueba-Timmermans DJ; Grootjen LN; Juriaans AF; Mahabier EF; Kerkhof GF; Rings EHHM; Hokken-Koelega ACS
    Eur J Endocrinol; 2023 Jul; 189(1):132-139. PubMed ID: 37440711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.
    Jin YY; Luo FH
    Eur J Pediatr; 2024 Mar; 183(3):1021-1036. PubMed ID: 37987848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone treatment for Prader-Willi syndrome: A review.
    Yang X
    Neuropeptides; 2020 Oct; 83():102084. PubMed ID: 32859387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.
    Myers SE; Whitman BY; Carrel AL; Moerchen V; Bekx MT; Allen DB
    Am J Med Genet A; 2007 Mar; 143A(5):443-8. PubMed ID: 17103437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.
    Rosenberg AGW; Passone CGB; Pellikaan K; Damiani D; van der Lely AJ; Polak M; Bernardo WM; de Graaff LCG
    J Clin Endocrinol Metab; 2021 Sep; 106(10):3068-3091. PubMed ID: 34105729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.
    Donze SH; Damen L; Mahabier EF; Hokken-Koelega ACS
    Eur J Endocrinol; 2020 Apr; 182(4):405-411. PubMed ID: 31961800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial.
    Kuppens RJ; Mahabier EF; Bakker NE; Siemensma EP; Donze SH; Hokken-Koelega AC
    Orphanet J Rare Dis; 2016 Nov; 11(1):153. PubMed ID: 27852283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone therapy, muscle thickness, and motor development in Prader-Willi syndrome: an RCT.
    Reus L; Pillen S; Pelzer BJ; van Alfen-van der Velden JA; Hokken-Koelega AC; Zwarts M; Otten BJ; Nijhuis-van der Sanden MW
    Pediatrics; 2014 Dec; 134(6):e1619-27. PubMed ID: 25422026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone levels in children with Prader-Willi syndrome: a randomized controlled growth hormone trial and 10-year growth hormone study.
    Trueba-Timmermans DJ; Grootjen LN; Kerkhof GF; Rings EHHM; Hokken-Koelega ACS
    Eur J Endocrinol; 2024 Aug; 191(2):126-133. PubMed ID: 39049789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: a randomized controlled trial.
    Reus L; Pelzer BJ; Otten BJ; Siemensma EP; van Alfen-van der Velden JA; Festen DA; Hokken-Koelega AC; Nijhuis-van der Sanden MW
    Res Dev Disabil; 2013 Oct; 34(10):3092-103. PubMed ID: 23886754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.
    Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Troeman ZC; van Alfen-van der Velden AA; Otten BJ; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Oostdijk W; Bocca G; Mieke Houdijk EC; van Trotsenburg AS; Hoorweg-Nijman JJ; van Wieringen H; Vreuls RC; Jira PE; Schroor EJ; van Pinxteren-Nagler E; Willem Pilon J; Lunshof LB; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2307-14. PubMed ID: 22508707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.
    Grugni G; Marzullo P
    Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):785-794. PubMed ID: 27974191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effect of Growth Hormone Treatment on Health-Related Quality of Life in Children with Prader-Willi Syndrome: A Randomized Controlled Trial and Longitudinal Study.
    Bakker NE; Siemensma EP; van Rijn M; Festen DA; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 84(4):231-9. PubMed ID: 26279206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
    Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
    J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
    Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
    Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.